Search
for
Sort by
Research 121–150 of 1000+
- 5α-Reductase inhibitors in androgenetic alopecia
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Novel inhibitors of 5α-reductase
- Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
- Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
- Condylomata acuminata of HIV-positive men may harbour focal areas of dysplasia: relevant implications for the management of human papillomavirus-induced disease in high-risk patients
- Cult of the Body Beautiful: At What Cost?
- Endocrine Regulation of Hair Growth and Loss: Current Evidence and Clinical Implications
- Hormone Blocking Anticancer Drugs
- Androstenedione
- Antiandrogen Therapy for Skin and Hair Disease
- Gonadal Dysgenesis: Associations between Clinical Features and Sex of Rearing.
- Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
- Androgen receptors and their biology
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- Congenital adrenal hyperplasia
- Skin diseases in consequence of endocrine alterations
- Alopecia and Hirsuties
- Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris
- Anti-androgen therapy in dermatology: a review
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications
- Hair Disorders
- Generalised Glucocorticoid Resistance
- Pathogenesis and causes of hirsutism
- Male androgenetic alopecia
- Formulation and evaluation of beta-sitosterol enriched herbal scalp serum
- Dermatologic therapy: December 1987 to December 1988
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- Sex differences in COVID-19: the role of androgens in disease severity and progression